<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kent LN</submitter><funding>NICHD NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>Washington University Department of Obstetrics and Gynecology</funding><pagination>441-448</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8934693</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>106(3)</volume><pubmed_abstract>Nuclear factor kappa B (NF-κB) transcriptionally regulates several genes involved in initiating uterine contractions. A key factor controlling NF-κB activity is its translocation to the nucleus. In myometrial smooth muscle cells (MSMCs), this translocation can be stimulated by the inflammatory molecule lipopolysaccharide (LPS) or by blocking the potassium calcium-activated channel subfamily M alpha 1 (KCNMA1 or BKCa) with paxilline (PAX). Here, we sought to determine the mechanism by which blocking BKCa causes NF-κB-p65 translocation to the nucleus in MSMCs. We show that LPS- and PAX-induced NF-κB-p65 translocation are similar in that neither depends on several mitogen-activated protein kinase pathways, but both require increased intracellular calcium (Ca2+). However, the nuclear transport inhibitor wheat germ agglutinin prevented NF-κB-p65 nuclear translocation in response to LPS but not in response to PAX. Blocking BKCa located on the plasma membrane resulted in a transient NF-κB-p65 nuclear translocation that was not sufficient to induce expression of its transcriptional target, suggesting a role for intracellular BKCa. We report that BKCa also localizes to the nucleus and that blocking nuclear BKCa results in an increase in nuclear Ca2+ in MSMCs. Together, these data suggest that BKCa localized on the nuclear membrane plays a key role in regulating nuclear Ca2+ and NF-κB-p65 nuclear translocation in MSMCs.</pubmed_abstract><journal>Biology of reproduction</journal><pubmed_title>Blocking the BKCa channel induces NF-κB nuclear translocation by increasing nuclear calcium concentration†.</pubmed_title><pmcid>PMC8934693</pmcid><funding_grant_id>R01 HD037831</funding_grant_id><pubmed_authors>England SK</pubmed_authors><pubmed_authors>Kent LN</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Weil SG</pubmed_authors><pubmed_authors>Wakle-Prabagaran M</pubmed_authors><pubmed_authors>Naqvi MZ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blocking the BKCa channel induces NF-κB nuclear translocation by increasing nuclear calcium concentration†.</name><description>Nuclear factor kappa B (NF-κB) transcriptionally regulates several genes involved in initiating uterine contractions. A key factor controlling NF-κB activity is its translocation to the nucleus. In myometrial smooth muscle cells (MSMCs), this translocation can be stimulated by the inflammatory molecule lipopolysaccharide (LPS) or by blocking the potassium calcium-activated channel subfamily M alpha 1 (KCNMA1 or BKCa) with paxilline (PAX). Here, we sought to determine the mechanism by which blocking BKCa causes NF-κB-p65 translocation to the nucleus in MSMCs. We show that LPS- and PAX-induced NF-κB-p65 translocation are similar in that neither depends on several mitogen-activated protein kinase pathways, but both require increased intracellular calcium (Ca2+). However, the nuclear transport inhibitor wheat germ agglutinin prevented NF-κB-p65 nuclear translocation in response to LPS but not in response to PAX. Blocking BKCa located on the plasma membrane resulted in a transient NF-κB-p65 nuclear translocation that was not sufficient to induce expression of its transcriptional target, suggesting a role for intracellular BKCa. We report that BKCa also localizes to the nucleus and that blocking nuclear BKCa results in an increase in nuclear Ca2+ in MSMCs. Together, these data suggest that BKCa localized on the nuclear membrane plays a key role in regulating nuclear Ca2+ and NF-κB-p65 nuclear translocation in MSMCs.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T09:02:33.311Z</modification><creation>2025-04-04T09:02:33.311Z</creation></dates><accession>S-EPMC8934693</accession><cross_references><pubmed>34791046</pubmed><doi>10.1093/biolre/ioab211</doi></cross_references></HashMap>